Results 161 to 170 of about 14,484 (178)

Incidence versus prevalence modeling in pharmacoeconomics

Expert Review of Pharmacoeconomics and Outcomes Research, 2002
Fadia T Shaya, C Daniel Mullins, Winston Wong   +2 more
exaly  

Pharmacoeconomics

2020
Dodel, Richard, Kruse, Christopher, Conrads-Frank, Annette, Siebert, Uwe   +3 more
openaire   +2 more sources

Interventional Pharmacoeconomics—A New Discipline for a Cost-Constrained Environment

JAMA Oncology, 2019
Mark J Ratain, Daniel A Goldstein, Allen S Lichter   +2 more
exaly  

Pharmacoeconomics of asthma treatment

Expert Opinion on Pharmacotherapy, 2003
Jennifer Cleland, David Price
exaly  

Pharmacoeconomics

2006
openaire   +2 more sources

Pharmacoeconomics of antifungal pharmacotherapy – challenges and future directions

Expert Opinion on Pharmacotherapy, 2005
Melissa D Johnson
exaly  

Pharmacoeconomics - an aid to better decision-making

Journal of the European Academy of Dermatology and Venereology, 2005
Antonella Tosti, R HAY, Eckart Haneke
exaly  

Pharmacoeconomics

2014
Andrea R. Chamberlain, Jaclyn E. Sawyer, David S. Cooper   +2 more
openaire   +1 more source

Pharmacoeconomics Education in US Colleges and Schools of Pharmacy

American Journal of Pharmaceutical Education, 2013
Tatiana Makhinova, Karen L Rascati
exaly  

Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia

Expert Review of Pharmacoeconomics and Outcomes Research, 2012
, Allison Krug, Leon E Cosler
exaly